Cargando…
Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain
New approaches to generate effective anticancer responses by either inducing immune responses or inhibiting immunosuppression are under development to improve efficacy in patients. On March 4-5(th), 2014, a symposium was held in Pamplona, Spain, to report the new strategies showing preclinical and c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112657/ https://www.ncbi.nlm.nih.gov/pubmed/25060862 http://dx.doi.org/10.1186/1479-5876-12-202 |
_version_ | 1782328201468444672 |
---|---|
author | Aznar, M Ángela Melero, Ignacio Quetglas, José I |
author_facet | Aznar, M Ángela Melero, Ignacio Quetglas, José I |
author_sort | Aznar, M Ángela |
collection | PubMed |
description | New approaches to generate effective anticancer responses by either inducing immune responses or inhibiting immunosuppression are under development to improve efficacy in patients. On March 4-5(th), 2014, a symposium was held in Pamplona, Spain, to report the new strategies showing preclinical and clinical results regarding translational research efforts on the topic. Participants interacted through oral presentations of 15 speakers and further discussions on topics that included novel therapeutic agents for cancer immunotherapy, viral vectors and interferon-based approaches, experimental tumor imaging and immunostimulatory monoclonal antibodies. Promising agents to target cancer cells and therapeutic approaches that are under translation from bench to patients were presented. |
format | Online Article Text |
id | pubmed-4112657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41126572014-07-29 Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain Aznar, M Ángela Melero, Ignacio Quetglas, José I J Transl Med Meeting Report New approaches to generate effective anticancer responses by either inducing immune responses or inhibiting immunosuppression are under development to improve efficacy in patients. On March 4-5(th), 2014, a symposium was held in Pamplona, Spain, to report the new strategies showing preclinical and clinical results regarding translational research efforts on the topic. Participants interacted through oral presentations of 15 speakers and further discussions on topics that included novel therapeutic agents for cancer immunotherapy, viral vectors and interferon-based approaches, experimental tumor imaging and immunostimulatory monoclonal antibodies. Promising agents to target cancer cells and therapeutic approaches that are under translation from bench to patients were presented. BioMed Central 2014-07-24 /pmc/articles/PMC4112657/ /pubmed/25060862 http://dx.doi.org/10.1186/1479-5876-12-202 Text en Copyright © 2014 Aznar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Meeting Report Aznar, M Ángela Melero, Ignacio Quetglas, José I Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title | Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title_full | Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title_fullStr | Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title_full_unstemmed | Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title_short | Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain |
title_sort | routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th march 2014, center for applied medical research and university clinic, pamplona, spain |
topic | Meeting Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112657/ https://www.ncbi.nlm.nih.gov/pubmed/25060862 http://dx.doi.org/10.1186/1479-5876-12-202 |
work_keys_str_mv | AT aznarmangela routingcancerimmunologyandimmunotherapyfromthelabtotheclinic45thmarch2014centerforappliedmedicalresearchanduniversityclinicpamplonaspain AT meleroignacio routingcancerimmunologyandimmunotherapyfromthelabtotheclinic45thmarch2014centerforappliedmedicalresearchanduniversityclinicpamplonaspain AT quetglasjosei routingcancerimmunologyandimmunotherapyfromthelabtotheclinic45thmarch2014centerforappliedmedicalresearchanduniversityclinicpamplonaspain |